Literature DB >> 8094086

Immunocytochemical localization of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in human endocrine pancreas.

A Martínez1, L M Montuenga, D R Springall, A Treston, F Cuttitta, J M Polak.   

Abstract

We studied the distribution of the enzymes that are involved in the post-translational alpha-amidation of regulatory peptides in human endocrine pancreas, using immunocytochemical methods for light and electron microscopy. Immunoreactivity for the two enzymes involved, peptidylglycine alpha-hydroxylating monooxygenase (PHM) and peptidyl-alpha-hydroxyglycine alpha-amidating lyase (PAL), was located in the periphery of the islets of Langerhans and in ductal endocrine cells. Staining of reverse-face serial sections demonstrated that these immunoreactivities co-localize with glucagon but not with pancreatic polypeptide (PP), insulin, or somatostatin. Double immunogold staining for electron microscopy confirmed the previous results and revealed a different localization for each enzyme inside the secretory granule: PHM is present in the central core of the glucagon-containing granules, whereas PAL is predominantly located near the granule membrane. The existence of an amidated peptide, GLP1, in the A-cells explains the presence of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in these cells. The absence of the enzymes in the PR-cells raises the possibility that a different form of amidating enzyme may be involved in the post-translational processing of this peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094086     DOI: 10.1177/41.3.8094086

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

Review 1.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Expression of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors.

Authors:  A Martínez; A M Treston; L Saldise; L M Montuenga; R I Linnoila
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  Peptidylglycine alpha-amidating monooxygenase (PAM) immunoreactivity and messenger RNA in human pituitary and increased expression in pituitary tumours.

Authors:  J H Steel; A Martínez; D R Springall; A M Treston; F Cuttitta; J M Polak
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

4.  Distribution of peptidyl-glycine alpha-amidating monooxygenase immunoreactivity in the brain, pituitary and islet organ of the anglerfish (Lophius americanus).

Authors:  J K McDonald; K Klein; B D Noe
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

Review 5.  Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination.

Authors:  Martin Doseděl; Eduard Jirkovský; Kateřina Macáková; Lenka Kujovská Krčmová; Lenka Javorská; Jana Pourová; Laura Mercolini; Fernando Remião; Lucie Nováková; Přemysl Mladěnka
Journal:  Nutrients       Date:  2021-02-13       Impact factor: 5.717

6.  Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells.

Authors:  Soren K Thomsen; Anne Raimondo; Benoit Hastoy; Shahana Sengupta; Xiao-Qing Dai; Austin Bautista; Jenny Censin; Anthony J Payne; Mahesh M Umapathysivam; Aliya F Spigelman; Amy Barrett; Christopher J Groves; Nicola L Beer; Jocelyn E Manning Fox; Mark I McCarthy; Anne Clark; Anubha Mahajan; Patrik Rorsman; Patrick E MacDonald; Anna L Gloyn
Journal:  Nat Genet       Date:  2018-07-27       Impact factor: 38.330

7.  Peptidylglycine monooxygenase activity of monomeric species of growth hormone.

Authors:  John Donlon; Patrick Ryan
Journal:  Heliyon       Date:  2019-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.